Robinswood Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.7K Buy
1,524
+198
+15% +$5.18K 0.01% 176
2026
Q1
$37.2K Buy
1,326
+83
+7% +$2.21K 0.01% 164
2025
Q4
$31K Buy
1,243
+17
+1% +$429 0.01% 181
2025
Q3
$31.3K Sell
1,226
-197
-14% -$4.86K 0.01% 174
2025
Q2
$34.5K Sell
1,423
-748
-34% -$17.4K 0.01% 168
2025
Q1
$55K Buy
2,171
+824
+61% +$21.6K 0.02% 125
2024
Q4
$35.7K Sell
1,347
-58
-4% -$1.57K 0.01% 139
2024
Q3
$40.7K Sell
1,405
-351
-20% -$10.2K 0.02% 140
2024
Q2
$49.1K Buy
1,756
+566
+48% +$15.6K 0.02% 124
2024
Q1
$33K Hold
1,190
0.01% 113
2023
Q4
$34.3K Hold
1,190
0.01% 102
2023
Q3
$39.5K Hold
1,190
0.02% 91
2023
Q2
$43.6K Buy
+1,190
New +$46.3K 0.02% 85

Other funds holding PFE

Robinswood Financial's PFE Position: Q2 2026 in Review

Robinswood Financial increased its Pfizer (PFE) stake by 15% in Q2 2026, buying an estimated $5.18K and bringing the position to 1,524 shares worth $36.7K. The position accounts for 0.01% of the portfolio, ranked #176.

Robinswood Financial first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $55K in Q1 2025. 1,257 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Robinswood Financial held 1,524 shares of Pfizer worth $36.7K as of Q2 2026.
  • Robinswood Financial bought 198 Pfizer shares in Q2 2026, an estimated $5.18K.
  • Pfizer made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #176 holding.
  • Robinswood Financial first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
  • Robinswood Financial's Pfizer position peaked at $55K in Q1 2025.
  • 1,257 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.